Insider · CIK 0001436707
Christopher M Smith
ceoofficerdirector
Files at NEO (NEOGENOMICS INC), PACB (PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Stock Option (right to buy)derivative | +32,500 | $0.00 | $0 | 32,500 | Jun 6, 2025 |
| May 11, 2024 | NEO NEOGENOMICS INC | MOption exercise Common Stock | +48,063 | $0.00 | $0 | 650,282 | Dec 4, 2024 |
| May 11, 2024 | NEO NEOGENOMICS INC | FTax withholding Common Stock | -18,913 | $14.86 | $281k | 631,369 | Dec 4, 2024 |
| May 11, 2024 | NEO NEOGENOMICS INC | MOption exercise Restricted Stock Unitderivative | -48,063 | $0.00 | $0 | 96,127 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.